REPLY: Data Reply, Concept Reply and Storm Reply, part of the Reply group, achieve AWS Automotive Competency Status
6.9.2023 10:30:00 EEST | Business Wire | Press release
Reply, a global systems integrator and consulting firm, announced today that three companies in its network - Concept Reply, Data Reply and Storm Reply have achieved Amazon Web Services (AWS) Automotive Competency status. This specialization recognizes these companies for their expertise in providing customers professional services and/or software solutions delivering transformation across an Automotive company’s operating model.
As Automotive customers leverage cloud to innovate and transform their operating model, they are looking for cloud experts with deep automotive experience. AWS Automotive Competency Partners provide customers with solutions and services across their digital transformation journey while being assured, they have support from a validated AWS Partner to meet their needs. These solutions follow AWS best practices for building secure, high-performing, resilient, and efficient cloud infrastructure for industry applications.
Achieving AWS Automotive Competency status differentiates Concept Reply, Data Reply and Storm Reply as AWS Partner Network (APN) members with demonstrated technical proficiency and proven customer success in running cloud solutions on AWS for the automotive industry. This program showcases automotive AWS Partners who have domain knowledge and are providing cloud services. To receive the AWS Automotive Competency designation, AWS Partners must undergo rigorous technical validation and provide vetted customer references.
"We are delighted to receive this recognition from AWS. Achieving AWS Automotive Competency status exemplifies our ability to deliver cutting-edge and complex technological projects, showcasing a deep understanding of the rapidly evolving market, particularly with the advancements in connected vehicles and electrification," said Filippo Rizzante, Reply's CTO. “At Reply, we take pride in empowering our customers to enhance their operational efficiency and embrace the future of the industry through the utilization of AWS."
Thanks to the combination of customer’s processes knowledge and technological skills on AWS, Reply supports some of the most important players in the automotive sector. From connected car solutions to Digital Customer Engagement and advanced analytics, Reply’s cutting-edge solutions powered by AWS help customers navigate the rapidly changing landscape of the sector.
Gregor Endl, Head of Cloud Operations at AUDI AG, added, “Reply helped us accelerate our cloud transformation on AWS at Audi AG. We congratulate them for the achievement of being an AWS Automotive Competency Launch Partner and look forward to continuing our successful collaboration.”
AWS is enabling scalable, flexible, and cost-effective solutions from startups to global enterprises. To support the seamless integration and deployment of these solutions, the AWS Competency Program helps customers identify AWS Partners with deep industry experience and expertise.
Reply
Reply [EXM, STAR: REY] specializes in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialized companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organizations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Data Reply
Data Reply is the Reply Group company specialized in Big Data Analytics and Artificial Intelligence. Through multidisciplinary teams of specialists in Big Data Engineering, Data Science and Intelligent Process Automation, Data Reply supports companies from different industries in process optimization through the design and implementation of solutions, quantum algorithms and Machine Learning and Artificial Intelligence models. www.data.reply.com
Concept Reply
Concept Reply, part of the Reply Network, is a leader in IoT solutions. They support and advise customers across Automotive, Manufacturing, Smart Infrastructure and beyond in all aspects of Internet of Things (IoT) and Cloud Computing. From designing and developing customized IoT solutions to implementing and managing them seamlessly, Concept Reply helps customers unlock the potential of IoT. www.concept.reply.com
Storm Reply
Storm Reply is an AWS Premier Consulting Partner and the specialist for professional cloud computing services in the Reply network. Through consolidated expertise and many years of experience in the creation and management of Data and Analytics solutions, Infrastructure as a Service (IaaS), Software as a Service (SaaS), and Platform as a Service (PaaS), Storm Reply supports global clients in the implementation of cloud-based systems and applications. Our goal is to use the cloud to create added value for mid-sized and large companies and to help them exploit the full potential of the cloud. www.storm.reply.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230906414526/en/
Contact information
Media:
Reply
Fabio Zappelli
f.zappelli@reply.com
Tel. +390117711594
Aaron Miani
a.miani@reply.com
Tel. +442077306000
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom